L
LLY
Eli Lilly & Co.
$1,208.74
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Eli Lilly & Co. in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
$9.09
Yield
0.75%
EPS
$29.80
P/E
41.5
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $10.03
Oct 29
Posts
About Eli Lilly & Co.
Eli Lilly is a large US drugmaker that develops and sells prescription medicines. Its biggest products today are the diabetes and weight-loss drugs Mounjaro and Zepbound, and it also sells cancer, immune, and other treatments. It earns money by selling these drugs, which patents protect from cheap copies for years.